Screener
Eligibility screening
A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes
1 US site in TX
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes
1 US site in TX
Before we begin
Your answer affects how the questions are phrased.